PAPILLARY THYROID CARCINOMA IN A LACTATING MOTHER

Authors

  • M.A. TAHER Director & CMO, Centre for Nuclear Medicine and Ultrasound, Box-16, Rangpur-5400, Bangladesh.

Keywords:

lodine-131 therapy, thyroid cancer, lactation

Abstract

Radioiodine ablation of post-thyroidectomy remnant was delayed successfully in a lactating mother suffering from papillary carcinoma of thyroid gland. However, daily dose of thyroxine (100 micrograms per day) was enough to suppress her cancer for many months as shown in the case reported below documented by clinical followups and whole body scans

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Honour AJ, Myant NB, Rowlands EN. Secretion of radioiodine in digestive juices and milk in man. Clin Sci 1952; 11: 447-462.

Miller H, Weetch RS. The excretion of radioactive iodine in human milk. Lancet 1955; 269: 1013.

Numberger CE, Lipscomb A. Transmission of radioiodine (I-131) to infants through human maternal milk. JAMA 1952;150: 1398-1400.

Weaver JC, Kamm ML, Dobson RL. Excretion of radioiodine in human milk. JAMA 1960; 173: 872-875.

Rubow S, Klopper J. Excretion of radioiodine in human milk following a therapeutic dose of I-131. Eur J Nucl Med 1988; 14: 632-633.

Downloads

Published

2023-04-22

How to Cite

1.
TAHER M. PAPILLARY THYROID CARCINOMA IN A LACTATING MOTHER. ASEAN J Radiol [Internet]. 2023 Apr. 22 [cited 2025 Jan. 31];12(1):37-8. Available from: https://asean-journal-radiology.org/index.php/ajr/article/view/758

Issue

Section

Original Article

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.